Last reviewed · How we verify
NCT05647824
User Performance of the TV4 BGMS
trial testing Capillary Testing in Diabetes Mellitus in 402 participants. Completed in 23 July 2020.
20 March 2020
Quick facts
| Lead sponsor | Ascensia Diabetes Care |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 402 |
| Start date | 5 February 2020 |
| Primary completion | 20 March 2020 |
| Estimated completion | 23 July 2020 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Capillary Testing
- Alternative Site Testing (AST)
- Venous Testing
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Ascensia Diabetes Care
Who can join
18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Thunder V4 (TV4) is the code name of a blood glucose monitoring system (BGMS) consisting of a new meter and new Contour FIT test strips. This clinical trial will assess the performance (accuracy) of the TV4 meter by lay users enrolled as subjects in the study, and by health care professionals (also called study staff).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05647824
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Ascensia Diabetes Care trials
Trials by the same sponsor.
- NCT06053593 — Ketostix® and Keto-Diastix® Performance Study · completed
- NCT05449795 — Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults · completed
- NCT05467345 — Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples · completed
- NCT04033315 — Performance of the L-PLUS BGMS by Persons With Diabetes Mellitus · completed
- NCT04008836 — User Performance of the Thunder Plus BGMS · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05647824 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ascensia Diabetes Care
- Last refreshed: 2 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05647824.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing